Adult Congenital Heart Disease Medico-Surgical Unit, Georges Pompidou European Hospital, 75015 Paris, France; Paediatric and Congenital Heart Disease Department, Necker Hospital, 75015 Paris, France.
Adult Congenital Heart Disease Medico-Surgical Unit, Georges Pompidou European Hospital, 75015 Paris, France.
Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):455-464. doi: 10.1016/j.acvd.2020.12.005. Epub 2021 Apr 10.
With the growing adult congenital heart disease (ACHD) population, the number of catheter ablation procedures is expected to dramatically increase. Data reporting experience and evolution of catheter ablation in patients with ACHD, over a significant period of time, remain scarce.
We aimed to describe temporal trends in volume and outcomes of catheter ablation in patients with ACHD.
This was a retrospective observational study including all consecutive patients with ACHD undergoing attempted catheter ablation in a large tertiary referral centre over a 15-year period. Acute procedural success rate and freedom from recurrence at 12 and 24 months were analysed.
From November 2004 to November 2019, 302 catheter ablations were performed in 221 patients with ACHD (mean age 43.6±15.0 years; 58.9% male sex). The annual number of catheter ablations increased progressively from four to 60 cases per year (P<0.001). Intra-atrial reentrant tachycardia/focal atrial tachycardia was the most common arrhythmia (n=217, 71.9%). Over the study period, acute procedural success rate increased from 45.0% to 93.4% (P<0.001). Use of irrigated catheters (odds ratio [OR] 4.03, 95% confidence interval [CI] 1.86-8.55), a three-dimensional mapping system (OR 3.70, 95% CI 1.72-7.74), contact force catheters (OR 3.60, 95% CI 1.81-7.38) and high-density mapping (OR 3.69, 95% CI 1.82-8.14) were associated with acute procedural success. The rate of freedom from any recurrence at 12 months increased from 29.4% to 66.2% (P=0.001). Seven (2.3%) non-fatal complications occurred.
The number of catheter ablation procedures in patients with ACHD has increased considerably over the past 15 years. Growing experience and advances in ablative technologies appear to be associated with a significant improvement in acute and mid-term outcomes.
随着成人先天性心脏病(ACHD)患者人数的增加,预计导管消融手术的数量将大幅增加。在很长一段时间内,关于 ACHD 患者导管消融的经验数据报告和演变仍然很少。
我们旨在描述 ACHD 患者导管消融的数量和结果的时间趋势。
这是一项回顾性观察研究,纳入了在一家大型三级转诊中心进行的 15 年期间接受尝试性导管消融的所有连续 ACHD 患者。分析了急性程序成功率和 12 个月和 24 个月时无复发的比例。
2004 年 11 月至 2019 年 11 月,221 例 ACHD 患者进行了 302 例导管消融(平均年龄 43.6±15.0 岁;58.9%为男性)。导管消融的年数量从每年 4 例增加到 60 例(P<0.001)。房间内折返性心动过速/局灶性心房性心动过速是最常见的心律失常(n=217,71.9%)。在研究期间,急性程序成功率从 45.0%增加到 93.4%(P<0.001)。使用灌流导管(比值比 [OR] 4.03,95%置信区间 [CI] 1.86-8.55)、三维标测系统(OR 3.70,95%CI 1.72-7.74)、接触力导管(OR 3.60,95%CI 1.81-7.38)和高密度标测(OR 3.69,95%CI 1.82-8.14)与急性程序成功率相关。12 个月时无任何复发的比例从 29.4%增加到 66.2%(P=0.001)。发生了 7 例(2.3%)非致命性并发症。
过去 15 年来,ACHD 患者的导管消融数量大幅增加。经验的不断增加和消融技术的进步似乎与急性和中期结果的显著改善有关。